The present invention relates to a type XVI collagen assay and its use in evaluating diseases associated with type XVI collagen, in particular colorectal cancer and ulcerative colitis, and for identifying a subgroup of patients with 5 Crohn's disease that have (or are likely to develop) fibrostenotic strictures.
展开▼